Skip to content

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02404688
Acronym
THC-ETOH
Enrollment
40
Registered
2015-03-31
Start date
2015-12-31
Completion date
2025-12-31
Last updated
2025-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cannabis, Alcohol Effect, Driving Under the Influence of Alcohol and Other Drugs

Brief summary

The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.

Detailed description

To study the effects of ethanol clamped at BAC 0.04% and THC (1.05 mg in a 70 kg individual) on driving.

Interventions

Low dose (0.015 mg/kg = 1.05 mg in a 70 kg individual) THC, dissolved in alcohol. This dose is roughly equivalent to smoking approximately 1/4 of a marijuana cigarette, or joint. Administered over 20 minutes.

DRUGPlacebo

Control: small amount of alcohol (quarter teaspoon), with no THC. Administered over 20 minutes.

Target BrAC of 0.04% reached over 20 minutes and then clamped to maintain this dose for an additional 60 minutes. This dose is equivalent to consuming approximately 2 drinks over 1 hour. Administered over a total of 80 minutes.

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Males or females 21 to 55 years of age (extremes included). * Exposed to cannabis at least once. * Exposed to alcohol at least once. * Able to provide informed consent.

Exclusion criteria

* Cannabis naive. * Alcohol naive. * Positive pregnancy screen * Hearing deficits.

Design outcomes

Primary

MeasureTime frameDescription
Road Tracking Errorbaseline, +20, +50, +120, +180 mins after start of alcohol and THC infusionchanges in road tracking errors between timepoints to assess the effects of alcohol and THC on road tracking errors.

Secondary

MeasureTime frameDescription
Visual Analog Scale (VAS)baseline, +20, +50, +120, +180 mins after start of alcohol and THC infusionFeeling states associated with alcohol and cannabis intoxication will be measured using this self-report scale of feeling states.
Cognitive Test Battery+40 mins after start of alcohol and THC infusionSeveral computer tasks will be administered to assess alcohol and THC effects on driving related cognition, including: visual vigilance, visual motor function, attention and working memory, and processing speed.
Biphasic Alcohol Effects Scale (BAES)baseline, +20, +50, +120, +180, +240 mins after start of alcohol and THC infusionA scale designed to assess the stimulant and sedative effects associated with alcohol intoxication.
Number of Joints Scalebaseline, +20, +50, +120, +180 mins after start of alcohol and THC infusionSubjects will be asked to rate the number of standard joints that they believe they have been administered.
Number of Drinks Scalebaseline, +20, +50, +120, +180 mins after start of alcohol and THC infusionSubjects will be asked to rate the number of standard drinks that they believe they have been administered.
Willingness to Drive Scalebaseline, +20, +50, +120, +180 mins after start of alcohol and THC infusionSubjects will be asked to rate their willingness to drive at their current state in the context of various scenarios including willingness to drive from testing facility to a number of destinations that are different driving distances.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026